SearchSearch result list

We actively accept patients from overseas and have an established track record. Our department provides a wide range of treatments for biliary and pancreatic cancers, from chemotherapy to surgical interventions, including minimally invasive procedures. With low mortality and complication rates, we are recognized as a high-volume center for biliary and pancreatic diseases. For initially unresectable pancreatic cancer, we employ multidisciplinary treatment strategies to achieve surgical resection. For benign diseases, we have extensive experience with minimally invasive surgery as the primary approach.

Our department is a pioneer in laparoscopic and robotic surgery, equipped with two different surgical robot systems, da Vinci and Hinotori, through which we provide highly advanced, high-quality minimally invasive surgery.
In addition to robot-assisted procedures, we also perform endoscopic laser treatments for urinary stone disease and benign prostatic hyperplasia (BPH), utilizing multiple state-of-the-art laser devices. For prostate biopsy, we employ MRI-fusion guided biopsy.

Our center performs approximately 100 esophageal cancer surgeries annually and serves as an opinion leader in the field, not only in robotic-assisted procedures using systems such as da Vinci and Hinotori, but also in a wide range of complex surgeries including tracheal resection and larynx-preserving procedures for advanced esophageal cancer. We also have surgeons who are capable of providing care in both English and Chinese.

We offer high-quality health check-ups conducted by practicing university hospital physicians. To ensure comfort, we also have a dedicated women-only area where women can undergo specialized screenings in a relaxed environment.

We offer high-quality health check-ups conducted by practicing university hospital physicians. To ensure comfort, we also have a dedicated women-only area where women can undergo specialized screenings in a relaxed environment.

With the MR linear accelerator system, a high-precision cancer radiotherapy system, and the da Vinci Xi, a state-of-the-art surgical support robot, a wide range of minimally invasive surgeries are expected to shorten treatment time and improve treatment efficacy, reducing the burden on patients and providing safer and more advanced team medicine.